A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Recruiting · NCT06997627 · Registry updated 2025-07-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults | Tetanus-diphtheria-acellular Pertussis (Tdap) | Recruiting | Phase 1 / Phase 2 | 2025-07-10 | NCT06997627 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GC Biopharma Corp | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Catholic Univ. of Korea Eunpyeong St. Mary's Hospital | Seoul | South Korea | 1 |